Adolescent Use of Flavored Non-Tobacco Oral Nicotine Products
- PMID: 35934731
- PMCID: PMC9994602
- DOI: 10.1542/peds.2022-056586
Adolescent Use of Flavored Non-Tobacco Oral Nicotine Products
Abstract
Background and objectives: Flavored non-tobacco oral nicotine products (eg, nicotine pouches and nontherapeutic nicotine gum, lozenges, tablets, gummies), are increasingly marketed in the United States. Prevalence of non-tobacco oral nicotine product use among adolescents is unknown.
Methods: We calculated prevalence of ever and past 6-month use of nicotine pouches, other non-tobacco oral nicotine products (ie, gum, lozenges, tablets, and/or gummies), e-cigarettes, cigarettes, hookah or waterpipe, cigars, cigarillos, and snus among high school students in Southern California between September and December 2021. Generalized linear mixed models tested associations of sociodemographic factors and tobacco-product use with use of any non-tobacco oral nicotine product.
Results: Among the sample (n = 3516), prevalence was highest for e-cigarettes (ever: 9.6%, past 6-month: 5.5%), followed by non-tobacco oral nicotine products (ever: 3.4%, past 6-month: 1.7%), and <1% for other products. Ever users of combustible tobacco (adjusted odds ratio [aOR] = 77.6; 95% confidence interval [CI] = 39.7-152) and ever users of noncombustible tobacco (aOR = 40.4; 95% CI= 24.3-67.0) had higher odds of ever using non-tobacco oral nicotine products, compared to never users of combustible and noncombustible tobacco. Use of any non-tobacco oral nicotine product was greater for Hispanic (versus all other races/ethnicities except Asian, aOR = 2.58; 95% CI = 1.36-4.87), sexual minority (versus heterosexual, aOR=1.63; 95% CI = 1.03-2.57), gender minority (versus male, aOR = 2.83; 95% CI = 1.29-6.19), and female (versus male, aOR=1.92, 95% CI = 1.20-3.06) participants.
Conclusions: Non-tobacco oral nicotine products were the second most prevalent nicotine product used by adolescents. They were disproportionately used by certain racial or ethnic, sexual, or gender minority groups, and those with a history of nicotine use. Adolescent non-tobacco oral nicotine product use surveillance should be a public health priority.
Copyright © 2022 by the American Academy of Pediatrics.
Conflict of interest statement
Figures
References
-
- Plurphanswat N, Hughes JR, Fagerström K, Rodu B. Initial information on a novel nicotine product. Am J Addict. 2020;29(4):279–286 - PubMed
-
- SAMHSA. Key substance use and mental health indicators in the United States: results from the 2020 National Survey on Drug Use and Health. Available at: https://www.samhsa.gov/data/. Accessed January 18, 2022.
-
- Centers for Disease Control and Prevention. National Youth Risk Behavior Survey. Available at: www.cdc.gov/yrbs. Published 2019. Accessed January 18, 2022.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
